Filter
News & Insights
- Access & Channel
Specialty Therapies and Field Reimbursement Services: Driving Better Outcomes for Brands and Patients
Read More - Access & Channel
Payers are harnessing AI to enhance data utilization
Read More - Access & Channel
Red Nucleus acquires COEUS
Read More - Access & Channel
Market access on the Hill: what’s possible in the next two years
Read More - Access & Channel
A path for healthier patients: Integrated specialty pharmacy model
Read More - Access & Channel
NCPA calls for immediate freeze of Medicare Drug Price Negotiation to protect pharmacies and patients
Read More - Access & Channel
Navigating product launches under budget constraints
Read More - Access & Channel
Raise the Bar in Patient Experience
Read More - Access & Channel
Early market access decisions are key for biotech commercialization success
Read More - Access & Channel
FTC calls out significant markups by PBMs in the specialty generic drug market
Read More - Access & Channel
Attention to PBM vertical integration will continue through 2025
Read More - Access & Channel
Data show drug shortages are bigger than ever
Read More - Access & Channel
2025: Continued chaos at the retail pharmacy level
Read More - Access & Channel
HOSP names new president
Read More - Access & Channel
How data privacy impacts your copay programs
Read More - Access & Channel
2025 access trends
Read More - Access & Channel
Xevant launches GLP-1 Dashboard to tackle rising therapy costs
Read More - Access & Channel
Surescripts and TPG partner to address healthcare challenges
Read More - Access & Channel
Collaboration in copay: a new era for patient affordability in healthcare
Read More - Access & Channel
GoodRx to offer pay-over-time option on select meds
Read More